Pediatric Cardiac Surgery

AI saves time for pediatric cardiac ICU clinicians by identifying patients who need more attention, according to a presenter at the AIMed24 Annual Meeting.

In August, the FDA approved a novel miniaturized cardiac stent for infants and small children with coarctation of the aorta or pulmonary artery stenosis and can be expanded as they grew.

Texas Children’s Hospital was named the top hospital for pediatric cardiology and heart surgery in the 2024 to 2025 rankings by U.S. News & World Report for the eighth year in a row.

Stanford Medicine Children’s Health this year celebrated 50 years of pediatric heart transplants and more than 35 years of pediatric lung transplants, according to a press release.

Data from a large pediatric heart transplant recipient database suggest initiating statin therapy after transplant has no benefit on graft survival or freedom from cardiac allograft vasculopathy compared with no statin use.

Children who underwent cardiac surgery had a high medication burden that often persisted throughout adolescence, with medication expenditures often 10-fold higher compared with those who did not have heart surgery, data show.

Texas Children’s Hospital was named the top hospital for pediatric cardiology and heart surgery in the 2023 to 2024 rankings by U.S. News & World Report for the seventh consecutive year.

The first prospective FDA-regulated device trial using a pediatric ventricular assist device registry was launched in November. It could transform how research is conducted in children with advanced heart failure.

Perioperative corticosteroids did not improve in-hospital mortality for children who underwent cardiac surgery with cardiopulmonary bypass, though corticosteroids may reduce hospital length of stay, data show.

Emerging precision medicine therapies targeting the molecular causes of cardiomyopathy and HF may improve the outlook for pediatric patients with HF, according to a review published in Translational Pediatrics.